Last updated on November 2017

Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension


Brief description of study

Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Detailed Study Description

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Clinical Study Identifier: TX8401

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinical Eye Research Center of ...

Clinical Eye Research Center of Connecticut
Danbury, CT USA
  Connect »